Editorial: risk of loss of response to anti TNF alpha in patients with inflammatory bowel diseases - the longer the less? Authors' reply: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply

DSpace/Manakin Repository

Editorial: risk of loss of response to anti TNF alpha in patients with inflammatory bowel diseases - the longer the less? Authors' reply: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply
 
Schultheiss, Johannes P D; Mahmoud, Remi; Fidder, Herma H; Oldenburg, Bas
(2022) Alimentary Pharmacology & Therapeutics, volume 55, issue 2, pp. 246 - 246
(Editorial)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Gastroenterology, Pharmacology (medical), Hepatology, Editorial
DOI: https://doi.org/10.1111/apt.16722
ISSN: 0269-2813
Publisher: Wiley-Blackwell
(Peer reviewed)